Clinical Trial Update: Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of retinoid 9cUAB30 in early-stage breast cancer reported a biologic effect; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 9cUAB30 (9cUAB30)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Status: TERMINATED | Results posted: 2024-05-22